Status:
COMPLETED
Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis
Lead Sponsor:
John Fowler
Conditions:
Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Thumb carpometacarpal osteoarthritis (CMC OA) affects up to 33% of people over the age of 40, which leads to inflammation, pain, and weakness of the CMC joint. Treatment modalities are both conservati...
Detailed Description
This pilot study seeks to investigate potential benefit in the use of Theraworx Foam in patients diagnosed with thumb CMC OA. Patients presenting to the upper extremity orthopedic surgery clinic for t...
Eligibility Criteria
Inclusion
- Thumb CMC arthritis
- greater than or equal to age 18
- Interested in non-operative treatment of thumb arthritis
Exclusion
- Recent corticosteroid injection into the thumb joint
- Non-English speaking
- skin lesions or rashes on the thumb
- current use of topical anti-inflammatory medications
- concomitant thumb/wrist diagnoses that would impact the results (as determined by the PI)
- known allergy to magnesium
Key Trial Info
Start Date :
December 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03770091
Start Date
December 21 2018
End Date
August 1 2020
Last Update
July 14 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaufmann Building
Pittsburgh, Pennsylvania, United States, 15213
2
Montefiore Hospital
Pittsburgh, Pennsylvania, United States, 15213
3
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213